drugset / Trial / NCT03750565
Multiple Dose Ethnobridging PK Study in Healthy Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
A Phase 1, double blind, placebo controlled, 4 cohort, multiple dose study in healthy adult Japanese and Caucasian subjects.
Timeline
- Start
- 2018-11-27
- Primary completion
- 2019-02-13
- Completion
- 2019-02-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IZENCITINIB | Small molecule | — | Oral |